Report Detail

Medical Industry Global Total Parenteral Nutrition (TPN) Solution Market Insights, Forecast to 2028

  • RnM4439537
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 108 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Table of Contents

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Amino Acid-Dextrose Solution
      • 1.2.3 Lipid Emulsions Solution
    • 1.3 Market by Application
      • 1.3.1 Global Total Parenteral Nutrition (TPN) Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospital
      • 1.3.3 Home
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Total Parenteral Nutrition (TPN) Solution Market Perspective (2017-2028)
    • 2.2 Total Parenteral Nutrition (TPN) Solution Growth Trends by Region
      • 2.2.1 Total Parenteral Nutrition (TPN) Solution Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Total Parenteral Nutrition (TPN) Solution Historic Market Size by Region (2017-2022)
      • 2.2.3 Total Parenteral Nutrition (TPN) Solution Forecasted Market Size by Region (2023-2028)
    • 2.3 Total Parenteral Nutrition (TPN) Solution Market Dynamics
      • 2.3.1 Total Parenteral Nutrition (TPN) Solution Industry Trends
      • 2.3.2 Total Parenteral Nutrition (TPN) Solution Market Drivers
      • 2.3.3 Total Parenteral Nutrition (TPN) Solution Market Challenges
      • 2.3.4 Total Parenteral Nutrition (TPN) Solution Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Total Parenteral Nutrition (TPN) Solution Players by Revenue
      • 3.1.1 Global Top Total Parenteral Nutrition (TPN) Solution Players by Revenue (2017-2022)
      • 3.1.2 Global Total Parenteral Nutrition (TPN) Solution Revenue Market Share by Players (2017-2022)
    • 3.2 Global Total Parenteral Nutrition (TPN) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Total Parenteral Nutrition (TPN) Solution Revenue
    • 3.4 Global Total Parenteral Nutrition (TPN) Solution Market Concentration Ratio
      • 3.4.1 Global Total Parenteral Nutrition (TPN) Solution Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Total Parenteral Nutrition (TPN) Solution Revenue in 2021
    • 3.5 Total Parenteral Nutrition (TPN) Solution Key Players Head office and Area Served
    • 3.6 Key Players Total Parenteral Nutrition (TPN) Solution Product Solution and Service
    • 3.7 Date of Enter into Total Parenteral Nutrition (TPN) Solution Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Total Parenteral Nutrition (TPN) Solution Breakdown Data by Type

    • 4.1 Global Total Parenteral Nutrition (TPN) Solution Historic Market Size by Type (2017-2022)
    • 4.2 Global Total Parenteral Nutrition (TPN) Solution Forecasted Market Size by Type (2023-2028)

    5 Total Parenteral Nutrition (TPN) Solution Breakdown Data by Application

    • 5.1 Global Total Parenteral Nutrition (TPN) Solution Historic Market Size by Application (2017-2022)
    • 5.2 Global Total Parenteral Nutrition (TPN) Solution Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Total Parenteral Nutrition (TPN) Solution Market Size (2017-2028)
    • 6.2 North America Total Parenteral Nutrition (TPN) Solution Market Size by Type
      • 6.2.1 North America Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2022)
      • 6.2.2 North America Total Parenteral Nutrition (TPN) Solution Market Size by Type (2023-2028)
      • 6.2.3 North America Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    • 6.3 North America Total Parenteral Nutrition (TPN) Solution Market Size by Application
      • 6.3.1 North America Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2022)
      • 6.3.2 North America Total Parenteral Nutrition (TPN) Solution Market Size by Application (2023-2028)
      • 6.3.3 North America Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    • 6.4 North America Total Parenteral Nutrition (TPN) Solution Market Size by Country
      • 6.4.1 North America Total Parenteral Nutrition (TPN) Solution Market Size by Country (2017-2022)
      • 6.4.2 North America Total Parenteral Nutrition (TPN) Solution Market Size by Country (2023-2028)
      • 6.4.3 United States
      • 6.4.4 Canada

    7 Europe

    • 7.1 Europe Total Parenteral Nutrition (TPN) Solution Market Size (2017-2028)
    • 7.2 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Type
      • 7.2.1 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2022)
      • 7.2.2 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Type (2023-2028)
      • 7.2.3 Europe Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    • 7.3 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Application
      • 7.3.1 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2022)
      • 7.3.2 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Application (2023-2028)
      • 7.3.3 Europe Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    • 7.4 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Country
      • 7.4.1 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Country (2017-2022)
      • 7.4.2 Europe Total Parenteral Nutrition (TPN) Solution Market Size by Country (2023-2028)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size (2017-2028)
    • 8.2 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Type
      • 8.2.1 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2022)
      • 8.2.2 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Type (2023-2028)
      • 8.2.3 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    • 8.3 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Application
      • 8.3.1 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2022)
      • 8.3.2 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Application (2023-2028)
      • 8.3.3 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    • 8.4 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Region
      • 8.4.1 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Region (2017-2022)
      • 8.4.2 Asia-Pacific Total Parenteral Nutrition (TPN) Solution Market Size by Region (2023-2028)
      • 8.4.3 China
      • 8.4.4 Japan
      • 8.4.5 South Korea
      • 8.4.6 Southeast Asia
      • 8.4.7 India
      • 8.4.8 Australia

    9 Latin America

    • 9.1 Latin America Total Parenteral Nutrition (TPN) Solution Market Size (2017-2028)
    • 9.2 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Type
      • 9.2.1 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2022)
      • 9.2.2 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Type (2023-2028)
      • 9.2.3 Latin America Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    • 9.3 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Application
      • 9.3.1 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2022)
      • 9.3.2 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Application (2023-2028)
      • 9.3.3 Latin America Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    • 9.4 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Country
      • 9.4.1 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Country (2017-2022)
      • 9.4.2 Latin America Total Parenteral Nutrition (TPN) Solution Market Size by Country (2023-2028)
      • 9.4.3 Mexico
      • 9.4.4 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size (2017-2028)
    • 10.2 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Type
      • 10.2.1 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Type (2017-2022)
      • 10.2.2 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Type (2023-2028)
      • 10.2.3 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Share by Type (2017-2028)
    • 10.3 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Application
      • 10.3.1 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Application (2017-2022)
      • 10.3.2 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Application (2023-2028)
      • 10.3.3 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Share by Application (2017-2028)
    • 10.4 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Country
      • 10.4.1 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Country (2017-2022)
      • 10.4.2 Middle East & Africa Total Parenteral Nutrition (TPN) Solution Market Size by Country (2023-2028)
      • 10.4.3 Turkey
      • 10.4.4 Saudi Arabia
      • 10.4.5 UAE

    11 Key Players Profiles

    • 11.1 Eurofarma
      • 11.1.1 Eurofarma Company Details
      • 11.1.2 Eurofarma Business Overview
      • 11.1.3 Eurofarma Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.1.4 Eurofarma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.1.5 Eurofarma Recent Developments
    • 11.2 Corporacion De Laboratorios Farmaceuticos
      • 11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
      • 11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
      • 11.2.3 Corporacion De Laboratorios Farmaceuticos Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments
    • 11.3 Baxter International Inc.
      • 11.3.1 Baxter International Inc. Company Details
      • 11.3.2 Baxter International Inc. Business Overview
      • 11.3.3 Baxter International Inc. Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.3.4 Baxter International Inc. Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.3.5 Baxter International Inc. Recent Developments
    • 11.4 Kelun Pharma
      • 11.4.1 Kelun Pharma Company Details
      • 11.4.2 Kelun Pharma Business Overview
      • 11.4.3 Kelun Pharma Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.4.4 Kelun Pharma Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.4.5 Kelun Pharma Recent Developments
    • 11.5 B. Braun
      • 11.5.1 B. Braun Company Details
      • 11.5.2 B. Braun Business Overview
      • 11.5.3 B. Braun Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.5.4 B. Braun Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.5.5 B. Braun Recent Developments
    • 11.6 Fresenius
      • 11.6.1 Fresenius Company Details
      • 11.6.2 Fresenius Business Overview
      • 11.6.3 Fresenius Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.6.4 Fresenius Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.6.5 Fresenius Recent Developments
    • 11.7 Teva Pharmaceutical Industries
      • 11.7.1 Teva Pharmaceutical Industries Company Details
      • 11.7.2 Teva Pharmaceutical Industries Business Overview
      • 11.7.3 Teva Pharmaceutical Industries Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.7.4 Teva Pharmaceutical Industries Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.7.5 Teva Pharmaceutical Industries Recent Developments
    • 11.8 Pfizer (Hospira)
      • 11.8.1 Pfizer (Hospira) Company Details
      • 11.8.2 Pfizer (Hospira) Business Overview
      • 11.8.3 Pfizer (Hospira) Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.8.4 Pfizer (Hospira) Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.8.5 Pfizer (Hospira) Recent Developments
    • 11.9 Ostuka Pharmaceutical
      • 11.9.1 Ostuka Pharmaceutical Company Details
      • 11.9.2 Ostuka Pharmaceutical Business Overview
      • 11.9.3 Ostuka Pharmaceutical Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.9.4 Ostuka Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.9.5 Ostuka Pharmaceutical Recent Developments
    • 11.10 Laboratorios Biogalenic
      • 11.10.1 Laboratorios Biogalenic Company Details
      • 11.10.2 Laboratorios Biogalenic Business Overview
      • 11.10.3 Laboratorios Biogalenic Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.10.4 Laboratorios Biogalenic Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.10.5 Laboratorios Biogalenic Recent Developments
    • 11.11 Laboratorios Finlay
      • 11.11.1 Laboratorios Finlay Company Details
      • 11.11.2 Laboratorios Finlay Business Overview
      • 11.11.3 Laboratorios Finlay Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.11.4 Laboratorios Finlay Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.11.5 Laboratorios Finlay Recent Developments
    • 11.12 Grifols International
      • 11.12.1 Grifols International Company Details
      • 11.12.2 Grifols International Business Overview
      • 11.12.3 Grifols International Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.12.4 Grifols International Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.12.5 Grifols International Recent Developments
    • 11.13 Fresenius Kabi
      • 11.13.1 Fresenius Kabi Company Details
      • 11.13.2 Fresenius Kabi Business Overview
      • 11.13.3 Fresenius Kabi Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.13.4 Fresenius Kabi Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.13.5 Fresenius Kabi Recent Developments
    • 11.14 Sichuan Kelun Pharmaceutical
      • 11.14.1 Sichuan Kelun Pharmaceutical Company Details
      • 11.14.2 Sichuan Kelun Pharmaceutical Business Overview
      • 11.14.3 Sichuan Kelun Pharmaceutical Total Parenteral Nutrition (TPN) Solution Introduction
      • 11.14.4 Sichuan Kelun Pharmaceutical Revenue in Total Parenteral Nutrition (TPN) Solution Business (2017-2022)
      • 11.14.5 Sichuan Kelun Pharmaceutical Recent Developments

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Author Details

      Summary:

      Market Analysis and Insights: Global Total Parenteral Nutrition (TPN) Solution Market
      The global Total Parenteral Nutrition (TPN) Solution market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
      Fully considering the economic change by this health crisis, Amino Acid-Dextrose Solution accounting for % of the Total Parenteral Nutrition (TPN) Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
      China Total Parenteral Nutrition (TPN) Solution market size is valued at US$ million in 2021, while the North America and Europe Total Parenteral Nutrition (TPN) Solution are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Total Parenteral Nutrition (TPN) Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Total Parenteral Nutrition (TPN) Solution market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Total Parenteral Nutrition (TPN) Solution market in terms of revenue.
      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Total Parenteral Nutrition (TPN) Solution market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Total Parenteral Nutrition (TPN) Solution market.
      Impact of Covid-19 Outbreak
      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
      Segmental Analysis
      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Total Parenteral Nutrition (TPN) Solution market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
      Total Parenteral Nutrition (TPN) Solution Breakdown Data by Type
      Amino Acid-Dextrose Solution
      Lipid Emulsions Solution
      Total Parenteral Nutrition (TPN) Solution Breakdown Data by Application
      Hospital
      Home
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA
      Competitive Landscape
      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
      Eurofarma
      Corporacion De Laboratorios Farmaceuticos
      Baxter International Inc.
      Kelun Pharma
      B. Braun
      Fresenius
      Teva Pharmaceutical Industries
      Pfizer (Hospira)
      Ostuka Pharmaceutical
      Laboratorios Biogalenic
      Laboratorios Finlay
      Grifols International
      Fresenius Kabi
      Sichuan Kelun Pharmaceutical
      Frequently Asked Questions
      What factors will challenge the Total Parenteral Nutrition (TPN) Solution market growth?
      Which end-use segment will expand at the fastest CAGR in the Total Parenteral Nutrition (TPN) Solution market?
      Which are the emerging players in the Total Parenteral Nutrition (TPN) Solution market?
      How concentrated is the Total Parenteral Nutrition (TPN) Solution market?
      Which factors are positively contributing to the Total Parenteral Nutrition (TPN) Solution market growth?
      Which are the novel product innovations in the Total Parenteral Nutrition (TPN) Solution market?
      Which product segment will emerge as the most lucrative in the Total Parenteral Nutrition (TPN) Solution market?
      Which factors are increasing the competition in the Total Parenteral Nutrition (TPN) Solution market?
      Which are the strategic measures taken by the Total Parenteral Nutrition (TPN) Solution industry players?
      Which region will witness inactive growth during the forecast period?
      What key trends are likely to emerge in the Total Parenteral Nutrition (TPN) Solution market in the coming years?


      Summary:
      Get latest Market Research Reports on Total Parenteral Nutrition (TPN) Solution. Industry analysis & Market Report on Total Parenteral Nutrition (TPN) Solution is a syndicated market report, published as Global Total Parenteral Nutrition (TPN) Solution Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Total Parenteral Nutrition (TPN) Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,462.60
      6,925.20
      4,080.30
      8,160.60
      555,538.50
      1,111,077.00
      336,994.50
      673,989.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report